The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kidron Nadav since year 2005.
The trader's CIK number is 1351779.
At the time of this reporting, Kidron Nadav is the President and CEO of Oramed Pharmaceuticals Inc. .
(stock ticker symbol ORMP).
See this page for all insider trading activities at Oramed Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-05-12||ORMP||Oramed Pharmaceuticals Inc.||Buy||1,000||6.98||6,978|
|2015-05-12||ORMP||Oramed Pharmaceuticals Inc.||Buy||600||6.61||3,966|
|2015-03-19||ORMP||Oramed Pharmaceuticals Inc.||Buy||1,600||3.96||6,331|
|2015-03-18||ORMP||Oramed Pharmaceuticals Inc.||Buy||1,000||3.79||3,790|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kidron Nadav (President and CEO of Oramed Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.